Quarterly report pursuant to Section 13 or 15(d)

Other Prepaid Expenses and Other Current Assets

v3.20.2
Other Prepaid Expenses and Other Current Assets
 9 Months Ended
Jun. 30, 2020
Other Prepaid Expenses and Other Current Assets  
Other Prepaid Expenses and Other Current Assets

6.  Other Prepaid Expenses and Other Current Assets

The Company’s prepaid expenses and other current assets consisted of the following:

 

 

 

 

 

 

 

 

 

 

June 30, 

 

September 30, 

 

    

2020

    

2019

Prepaid research and development expense

 

$

 —

 

$

223,510

Other income receivable

 

 

174,620

 

 

 —

Other prepaid expenses and other current assets

 

 

112,496

 

 

42,176

   Total

 

$

287,116

 

$

265,686

 

At June 30, 2020, the Company recognized a receivable associated with the income from a license of certain clinical trial data to a third party.